Back to search

Article

Comparative Long-Term Effectiveness Of OnabotulinumtoxinA (Botox) And Anti CGRP In Migraine Prevention: A Systematic Review

2024-06-20

Abstract excerpt

<h4>Background: </h4> Every year, 15% of the global population suffers from migraines, making it a substantial social burden with a significant negative impact on quality of life. This systematic review aims to evaluate the comparative efficacy, safety profiles, cost-effectiveness, and additional dimensions of two prominent chronic migraine (CM) prophylactics: OnabotulinumtoxinA (BoNT-A) and calcitonin gene-relate...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ef21656d-49c4-5b24-9223-c6ed8f085abf
DOI
10.12688/f1000research.151605.1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Comparative Long-Term Effectiveness Of OnabotulinumtoxinA (Botox) And Anti CGRP In Migraine Prevention: A Systematic ReviewDOI 10.12688/f1000research.151605.1
The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysisSemantic proximity
Impact of Botulinum Toxin Versus CGRP Monoclonal Antibodies on Return Visits and Acute Medication Use in Chronic Migraine: First Real-World, Multicenter, Head-to-Head Analysis Using TriNetXSemantic proximity
Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine – An updated systematic review and meta-analysisSemantic proximity
Cgrp Monoclonal Antibodies: Key Lessons from Real World EvidenceSemantic proximity
Efficacy of fremanezumab in refractory chronic migraine patients: Real-world data from the Hull Migraine Clinic, UKSemantic proximity
Comparative Efficacy and Safety of Calcitonin Gene-Related Peptide Monoclonal Antibodies Versus Oral Gepants for Episodic Migraine Prevention: A Bayesian Network Meta-Analysis of Randomized Controlled TrialsSemantic proximity
Efficacy and Safety of CGRP Monoclonal Antibodies for the Prevention of Migraine Compared with Placebo: A Systematic Review and Meta-AnalysisSemantic proximity
Effectiveness and Tolerability of Anti-Calcitonin Gene-related Peptide Therapy for Migraines and Other Chronic Headaches in Adolescents and Young Adults: A Retrospective Study in the USASemantic proximity
Different Dosage Regimens of Eptinezumab for the Treatment of Migraine: A Meta-Analysis from Randomized Controlled TrialsSemantic proximity
Monoclonal Antibodies Against Calcitonin Gene-related Peptide for Migraine Prophylaxis: A Systematic Review of Real-world DataSemantic proximity
Predictors of galcanezumab response in a real-world study of Korean patients with migraineSemantic proximity
Unveiling the Efficacy and Safety of Erenumab, a Monoclonal Antibody Targeting Calcitonin Gene-related Peptide (CGRP) Receptor, in Patients with Chronic and Episodic Migraine: A GRADE-assessed Systematic Review and Meta-analysis of Randomized Clinical Trials with Subgroup AnalysisSemantic proximity
Select a neighboring publication to make it the new centre.